Cargando…
Mechanisms of Normalisation of Bone Metabolism during Recovery from Hyperthyroidism: Potential Role for Sclerostin and Parathyroid Hormone
Sclerostin, a protein expressed by osteocytes, is a negative regulator of bone formation. The aim of the study was to investigate the relationship between parathyroid hormone (PTH) and markers of bone metabolism and changes of sclerostin concentrations before and after treatment of hyperthyroidism....
Autores principales: | Skowrońska-Jóźwiak, Elżbieta, Lewandowski, Krzysztof C., Adamczewski, Zbigniew, Krawczyk-Rusiecka, Kinga, Lewiński, Andrzej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4561097/ https://www.ncbi.nlm.nih.gov/pubmed/26366174 http://dx.doi.org/10.1155/2015/948384 |
Ejemplares similares
-
Successful treatment of thyrotoxicosis is accompanied by a decrease in serum sclerostin levels
por: Skowrońska-Jóźwiak, Elżbieta, et al.
Publicado: (2012) -
The Effect of Recombinant Human TSH on Sclerostin and Other Selected Bone Markers in Patients after Total Thyroidectomy for Differentiated Thyroid Cancer
por: Zygmunt, Arkadiusz, et al.
Publicado: (2021) -
Differences of the Structure of Immune Regulatory Cell Populations between Cellular Material from Sonographically Detected Focal Thyroid Lesions and Peripheral Blood in Humans
por: Stasiołek, Mariusz, et al.
Publicado: (2019) -
COX-2 expression in papillary thyroid carcinoma (PTC) in cytological material obtained by fine needle aspiration biopsy (FNAB)
por: Krawczyk-Rusiecka, Kinga, et al.
Publicado: (2011) -
Distribution of subpopulations of dendritic cells in peripheral blood of patients treated with exogenous thyrotropin
por: Stasiołek, Mariusz, et al.
Publicado: (2012)